BUY Glenmark PharmaceuticalsRajesh Satpute

byRajesh SatputeHorizon: NA (inferred Intraday)3 Jul 2026, 9:50 am ISTvia CNBC Awaaz.

Entry₹2,219.5Inferred
Target₹2,260
Total upside +1.82% (call closed)
Stop loss₹2,200-0.88% risk
Exit₹2,2003 Jul 2026, 10:54 am
Stop-loss hit-0.88%

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 8 Sept, 5:57 pm IST
1 supporting0 opposing
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.